T he mechanisms that underpin regulation of the balance between activation of immune cells to maximize reactivity to foreign Ags while minimizing responses to self are central to our understanding of immunity. Apoptosis plays a critical role in the development of immune cells and in the maintenance of tissue homeostasis. This is achieved through the regulation of apoptotic family members that shape the immune repertoire and terminate immune responses (1) . Whether a cell lives or dies is largely due to the interactions between antiapoptotic and proapoptotic members of the B cell lymphoma 2 (Bcl-2) family. The antiapoptotic proteins (Bcl-2, Bcl-X L , Bcl-W, A1, and Mcl-1) share sequence homology in their Bcl-2 homology (BH) domains. The proapoptotic members are divided into two groups: the multidomain proteins (e.g., Bax and Bak) and those that share similarity in the BH3 region (e.g., Bim/Bod, Bid, Bad, Noxa, Hrk/ DP5, Bik, Blk/NBk, Puma/Bbc3). This latter group of BH3-only proteins can bind to the prosurvival Bcl-2 family members thereby removing the inhibition of Bax and Bak and inducing apoptosis by permeabilizing the outer mitochondrial membrane (2, 3) .
In mammals, two pathways of apoptosis, the "Bcl-2-regulated" (also called "intrinsic" or "mitochondrial") and the "death receptor"-induced (also called "extrinsic") synergistically regulate the shutdown of CD8 + T cell responses after a chronic immune response (4, 5) . The relative contributions of each of these pathways vary depending on the nature of the response-acute versus chronic. In an acute immune response, cessation of lymphocyte recruitment and proliferation is thought to be triggered by a decline in cytokine levels and is mediated (largely) through activation of the BH3-only proteins Bcl-2 interacting mediator of cell death (Bim) and p53 upregulated modulator of apoptosis (Puma) (6) (7) (8) (9) . Bim and Puma, in contrast to other proapoptotic molecules, bind to all prosurvival Bcl-2-like proteins with high affinity and therefore play particularly prominent roles in the initiation of apoptosis (10, 11) . In chronic immune responses elicited by persistent pathogens or tissue self-antigens, the "death receptor" (Fas ligand [FasL] ) and the "Bcl-2-regulated" (Bim) pathways collaborate in effecting the removal of Ag-activated CD8 + T cells (12) (13) (14) . In this setting, the death receptor pathway is thought to be triggered by repeated TCR ligation-mediated induction of FasL, leading to autocrine and/or paracrine Fas stimulation, whereas Bim may be induced in response to a decline in cytokine levels or repeated TCR stimulation-induced calcium flux (5, 15, 16) . More recently, Bim, FasL, and BH3-interacting domain death agonist (Bid) have been shown to regulate collaboratively protection against fatal autoimmune hepatitis; however, a similar potential synergistic role in persistent infection has not yet been examined (17) .
Bid lies at the nexus of the extrinsic and intrinsic pathways: ligation of Fas results in caspase-8-mediated cleavage of Bid to tBid and its subsequent translocation to the mitochondria where the intrinsic death pathway is engaged (18) . Both acute and persistent pathogens have developed a number of strategies to co-opt components of the apoptotic machinery to impair cell death and to target components of the Bid pathway. Influenza A/PR/8/34 (PR8) virus is of particular interest as it encodes the basic polymerase 1 (basic polymerase 1-reading frame 2; PB1-RF2) (19) that is hypothesized to induce cell death by activating the Bcl-2-regulated apoptotic pathway by sensitizing mitochondria to the proapoptotic effects of t-Bid (20) . This mechanism is thought to be critical in defining influenza virus pathogenicity. Previously, we did not detect an effect of loss of Bid on the immune response to acute HSV-1 infection (8); however, it is important to determine whether the specific action of PB1-RF2 in influenza pathogenicity is mediated through Bid in vivo or by an alternate pathway. In addition to the purported action of influenza on Bid, persistent viruses such as herpes and pox viruses express viral FLIPs, which inhibit the activation of caspase-8, the enzyme that cleaves and activates Bid (21) . We therefore reasoned that Bid, similar to Bim, might regulate T cell expansion or contraction after acute and persistent infection either in a T cell intrinsic manner or by modulating the survival of APCs. In addition, given the synergistic interactions between Bim and FasL and the importance of Bid in linking these intrinsic and extrinsic pathways particularly in persistent infection, Bid might act with Bim to optimize T cell shutdown.
Materials and Methods

Mice
All mice were bred and maintained in specific pathogen-free conditions at the Walter and Eliza Hall Institute of Medical Research. Bid-deficient mice were generated on an inbred C57BL/6 background using C57BL/6-derived embryonic stem cells (22) 
Virus infections
Mice were anesthetized with methoxyflurane and then infected intranasally with 3 3 10 4 PFU recombinant murine g-herpesvirus-68 expressing ovalbumin (MHV-OVA) (24) or with 10 4.5 PFU HKx31 (H3N2; X31) influenza virus (25, 26) + CD8 + cells. In vitro-generated effector OT-I CD8 + T cells were labeled with CFSE (5 mM; Molecular Probes) by incubating 10 7 purified cells per milliliter with 5 mM CFSE for 10 min at 37˚C as previously described (27) . CFSElabeled effector OT-I CD8 + T cells (2.5 3 10 6 -5 3 10 6 ) were adoptively transferred by tail vein injection in 200 ml PBS into recipient mice.
Cell surface staining and FACS analysis
To block nonspecific binding of Abs, cells were incubated in rat IgG (1 mg/ ml) together with anti-FcgR mAb (CD16/32, clone 2-4G21) for 10 min on ice. Samples were then stained with fluorochrome-labeled Abs against CD11c (HL3), Va2 (B20.1), CD8a (53-6.7), CD62L (Mel-14), KLRG1 (2FY), IL-7R (A7R34), Ly5.1 (A20-1. 
Intracellular cytokine staining
To measure Ag-specific cytokine expression, CD8 + T cell-enriched splenocytes were stimulated with 1 mM OVA (OVA 257-264 ) or p79 (p79 ORF61 524-531 ) peptide in presence of Golgi Stop (BD Pharmingen) for 5 h. Cells were then stained for surface molecules CD8a (53-6.7), Ly5.1 (A20-1.1), and Ly5.2 (104), fixed and permeabilized using Cytofix/Cytoperm reagent (BD Biosciences), and then stained for intracellular IFN-g (anti-XMG 1.2-PE), TNF-a (MP6-XT22), and washed and analyzed by flow cytometry.
Lymphocyte isolation from the lung
Mononuclear cells were purified from the lung by generating single-cell suspensions, followed by centrifugation on Histopaque density gradient (1.077 g/ml; Sigma-Aldrich) for 18 min at 2000 rpm at room temperature. Lymphocytes from bronchoalveolar lavage were isolated by washing the lung three times with HEPES-buffered Eagle's medium supplemented with 2.5% FCS.
Dendritic cell enrichment
Dendritic cells (DCs) were purified from the spleen as previously described (28) .
In vitro generation of effector CD8 + T cells
Effector OT-I T cells were generated by culturing OT-I T cells with OVApulsed DCs (1 mg/ml OVA peptide) in complete RPMI 1640 medium (mouse tonicity RPMI 1640 containing 10% FCS, 50 mM 2-mercaptoethanol, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin) supplemented with 30 U/ml human recombinant IL-2. DCs were cultured with T cells at a ratio of 1:10. Cells were placed into fresh medium containing IL-2 after 3 d. On day 7 after initiation of the culture, cells were collected and subjected to a second round of stimulation with OVA peptide-pulsed DCs and then cultured for an additional 3 d prior to adoptive transfer.
Flow cytofluorometric assay for T cell-mediated cytotoxicity
OVA-specific CTLs were generated in vitro. DCs enriched from the spleens of wild-type (WT) or bid 2/2 mice were pulsed with 100 ng/ml OVA peptide for 1 h at 37˚C. Graded numbers of OT-I CTLs were incubated in 96-well round-bottom plates before the addition of 5 3 10 4 OVA peptidepulsed or unpulsed DC targets. After 3-h incubation at 37˚C, cells were washed and stained with mAbs against TCRVa2 (B20. 
Results
PB1-RF2-mediated pathogenicity is independent of Bid
Influenza infection of APCs is critical to induction of the T cell response. We hypothesized that if Bid is a major mediator of influenza virus pathogenicity (20) through the action of PB1-RF2, it would act through APCs as it does not efficiently infect T cells. Modification of Ag presentation by induction of death of APCs through the action of PB1-RF2 targeting the apoptotic pathway should result in differences in induction of CD8 + T cell responses. To test whether loss of Bid in host cells enhanced CD8 + T cell responses and protection against PB1-RF2-mediated cell death, we inoculated bid 2/2 and WT mice with one of two strains of influenza A virus, namely X31 or the parent strain, PR8. X31 is a recombinant influenza virus in which the non-coating genes (nucleoprotein NP, acid polymerase PA, basic polymerase PB1, PB2, non-structural NS1, NS2, matrix M1, M2) are derived from the PR8 virus and thus are completely homologous but can differ in pathogenicity. In C57BL/6 mice, intranasal infection with X31
generates a relatively mild respiratory infection compared with that of PR8, and it is speculated that the action of PB1-RF2 may be of greater importance in more highly pathogenic influenza infections. Thus, first we tracked whether loss of Bid enhanced recovery or protection after influenza infection. Primary infection with either of these influenza viruses resulted in similar weight loss in bid 2/2 and WT mice (Fig. 1A ) and no differences in lung histopathology (data not shown). In the more virulent PR8 infection (Fig. 1A , right panel), no statistical differences were observed in the number or timing of death of fatally affected mice. (Fig. 1B, X31 ; 1D, PR8) or at the time of established immunological memory (day 21) in the spleen, lung, or mediastinal LNs for either infection (Fig. 1B-D) . Similar results were obtained in mixed bone marrow chimeric mice in which bid 2/2 and WT cells exposed to similar Ag loads and cytokine milieu can be analyzed simultaneously for cell intrinsic differences during infection (data not shown). Thus, although PB1-RF2 can exert increased pathogenicity in some infectious settings as highlighted by mutation of this sequence (6, 7, 20, (29) (30) (31) , it does not appear to do this in vivo through a Bid-dependent pathway in mice as was initially predicted.
Loss of Bid causes accumulation of virus-specific CD8 + T cells during chronic infections
Next we asked whether Bid plays a role in persistent infection. To identify whether this might be the case, bid 2/2 or WT mice were infected with recombinant MHV-OVA by intranasal inoculation. This virus generates an acute lytic infection in the lung and mediastinal LNs after which it disseminates to the spleen and establishes persistent reservoirs (32, 33) . After 2 wk, the peak of lytic infection, there was no significant alteration in the total cell number, the activation status, or function (Supplemental Fig. 1 ) of virus-specific CD8 + T cells in the spleens of bid 2/2 infected mice compared with that in WT mice (Fig. 2) . Although loss of Bid at this early stage of infection did not cause any obvious change in lymphocyte numbers or viral titers, we further analyzed the immune response at later stages of MHV-OVA infection (days 72 and 120), when persistent exposure to Ag can drive changes in T cell homeostasis (Fig. 2) Fig. 2) . In this setting, T cells lacking Bid maintained their functional capacity to produce cytokines such as IFNg and TNF-a after short-term in vitro restimulation (Supplemental Fig. 4 ). This is consistent with our previous observations that T cells exposed to persistent g-herpesvirus (g-HV) maintain function (8, 13, 34) . Overall, these data suggest that Bid can play a role in the regulation of virus-specific CD8 + T cell homeostasis during persistent infection.
Virus-specific CD8
+ T cell accumulation in bid 2/2 is not driven by changes in DC life span BH3-only proteins have broad effects on the survival of immune cells. One explanation for the accumulation of bid 2/2 T cells is that they may be driven to increased proliferation secondary to enhanced survival of DCs in the absence of Bid. To determine whether differences in DC survival may be important, we isolated DCs from naive WT mice and mice deficient in BH3-only proteins Bid and Bim and followed their survival in vitro (Fig. 3A) . We did not observe any significant differences in survival between bid 2/2 and WT DCs, but bim 2/2 DCs did display a survival advantage (Fig. 3A) . This analysis, however, does not exclude the possibility that Bid may play a role in vivo when activated Ag-loaded DCs encounter primed and differentiated effector CD8 + T cells that kill DCs expressing cognate Ags. Indeed, granzyme B released by effector CD8 + T cells can cleave Bid in target cells, thereby activating the Bid-dependent apoptotic pathway (35, 36) . Thus, in the absence of Bid activation, DCs may be rendered more resistant to granzyme/perforin-mediated T cell-induced cytolysis. To investigate this, we established a cytofluorometric assay that allows the detection of apoptosis in small numbers of target cells (37) . Purified DCs from bid 2/2 and WT mice pulsed with OVA [257] [258] [259] [260] [261] [262] [263] [264] peptide were killed with equal efficiency by in vitro-activated OVA-specific CD8 + T cells suggesting that Bid deficiency does not protect DCs from T cell-mediated killing in this setting (Fig.  3B) . Furthermore, when DCs isolated from mice 14 d after MHV- OVA infection were examined, they showed equivalent levels of annexin V staining suggesting that infection itself did not alter the potential effects of loss of Bid (Fig. 3C) . Thus, collectively these data demonstrate that Bid does not contribute to the death of splenic DCs.
Bid intrinsically regulates the death of virus-specific T cells undergoing repeated antigenic stimulation
Given the above findings, it seemed likely that the key effects of Bid deficiency in T cells were intrinsic and mediated by increased resistance to cell death. To analyze specifically the cell intrinsic The Journal of Immunologyeffects of the loss of Bid on virus-specific CD8 + T cells after the peak of the response, we generated effector CD8 + T cells in vitro by activating OT-I CD8 + T cells using OVA-peptide pulsed DCs. Effector bid 2/2 OT-I (Ly.5.1/Ly5.2) and WT OT-I CD8 + (Ly5.2) T cells (.95% cells were CD62L
2 ) were labeled with CFSE, mixed in a 1:1 ratio, and adoptively transferred into either naive Ly5.1 mice or mice infected 3 d earlier with MHV-OVA virus (Fig.  4A ). This approach allowed parallel tracking of CD8 + T cells that either lacked or retained expression of Bid but that expressed a TCR of equivalent affinity and avidity. Three days after transfer, flow cytometric analysis of the dilution of CFSE showed that both bid 2/2 OT-I and WT OT-I CD8 + T cells proliferated similarly in the mediastinal LN and lungs of mice (Fig. 4B, top panels) . As expected at this early time point (6 d postinfection), proliferation was most prominent in the mediastinal LN (the site of immune activation) while few dividing cells were detected in the spleen of infected mice. However, at 12 d after transfer, at least 5-fold more bid 2/2 OT-I CD8 + T cells were detected in spleen and 3-fold more in the lungs compared with WT OT-I cells (Fig. 4B [lower panels] , 4C; Supplemental Fig. 3 ). By contrast, there was no difference in the number of bid 2/2 OT-I CD8 + T cells and WT OT-I CD8 + T cells in the spleens of naive mice over the same time frame indicating that both genotypes survived equally well at steady state (Fig. 4B, 4C ). Thus, Bid regulates the death of effector virusspecific CD8 + T when exposed to chronic Ag stimulation.
Bid cooperates with Bim to regulate virus-specific CD8 + T cell death during persistent virus infection
Although in the absence of Bid more CD8 + T cells accumulate in persistent infection, this failure to shut down the T cell response is more modest than what we have previously shown for Bim (13) . However, BH3-only proteins can act synergistically to ensure finetuning of the T cell shut-down process. For example, Bim and Fas cooperate to regulate T cell shutdown during persistent infection (13) . In addition, Bim, Bid, and Fas work collaboratively in regulating T cell shutdown in hepatitis that may occur under antigenic stimulation (17) . As Bid connects the death receptor and the Bcl-2-regulated apoptotic pathways, we asked whether the modest accumulation of bid 2/2 virus-specific T cells during repeated (Fig. 5A ).
The number of p79 specific CD8 + T cells was similar in both strains of mice consistent with our earlier findings in bid 2/2 mice perhaps suggesting the earlier elimination of infected cells by the increased OVA-specific CD8 + T cells (Figs. 2, 5 (Fig. 5B) .
Collectively, these data show that an unanticipated synergy exists between Bim and Bid in T cells responding to persistent Ag.
Discussion
In this study, we demonstrated that Bid does not contribute to death of Ag-specific CD8 + T cells during acute influenza infection. This is concordant with our previous observations using acute HSV-1 infection in bid 2/2 and WT mice (8) . Similar to the scenario observed in influenza and HSV-1 infection (8), the induction of g-HV-specific CD8 + T cells showed a pattern equivalent to that of WT mice. However, when we extended the analysis to examine late time points, over which time Ag is continuously expressed due to persistent infection, we uncovered a role for Bid in preventing the accumulation of virus-specific CD8 + T cells. population of cells that coexpressed KLRG1 and CD127. The nature of these cells is currently under investigation, but they could represent T cells that have only undergone partial activation and thus not down-modulated CD127 although we find no evidence for functional impairment (IFN-g and TNF-a secretion) (Supplemental Fig. 1, Supplemental Fig. 4) . In vitro repeated activation of virus-specific CD8 + T cells prior to transfer into mice chronically infected with g-HV mimicked the accumulation of bid 2/2 cells seen in endogenous T cell populations. Such an effect was not seen when effector CD8 + T cells were adoptively transferred into naive hosts. Although prolonged life span of APCs could perhaps account for such an effect, loss of Bid did not appear to alter survival of splenic DCs. Thus, the contribution of Bid to T cell survival in our studies reflects a T cell intrinsic effect. This cell intrinsic effect of Bid is reinforced by the outcome of adoptively transferred cells into WT infected hosts. It is striking that the phenotype of bid-deficient and bid/bim-deficient mice is less pronounced than that of the bim/fas double knockout mice (Bcl2l11 2/2 Fas lpr/lpr ) (13) . In this latter study, delineation of the independent intrinsic effects of the compound loss of Bim and Fas on T cells versus APCs was not assessed. Stranges et al. (38) demonstrated that Fas-dependent elimination of APCs is a major mechanism curbing immune responses in chronically activated T cells, particularly in the setting of autoimmunity . As such, prolonged Ag presentation in the absence of both bim and fas is likely to magnify significantly the amplification of T cells responding to infection where systemic loss of these regulators, rather than T cell-specific deletion, has been induced. This may account for the greater difference observed in the bim/fas-deficient mice, where both bim (Fig. 3) and fas (38) contribute to survival of DCs, compared with the bim/bid-deficient mice where only bim appears to impart significantly enhanced survival of DCs (Fig. 3) . Thus, it will be intriguing to delineate the precise contributions of T cell and APC intrinsic apoptotic mechanisms to overall control of T cells.
Specificity of action of BH3-only family members is exquisitely imparted by differential binding to their partner ligands. Bid can bind with high affinity to most Bcl-2 family members (except Bcl-2) (10) but does not appear to be required for shutdown of T cell responses in acute infections. This is possibly due to the requirement for caspase-8 activation downstream of death receptor signaling for Bid cleavage. Such a situation arises when a pathogen persists in the host long-term and periodically causes immune reactivation. The increased number of virus-specific T cells in bid/ bim double knockout mice compared with mice lacking Bim alone suggests that the death receptor apoptotic pathway requires Bid to eliminate virus-specific T cells under some circumstances. Thus, Bid appears not to be essential in the Fas-mediated induced T cell death, but importantly acts to amplify the synergy with Bim and Fas in regulating of T cell death in the setting of persistent infection.
In summary, both the intrinsic (Fas-independent) and extrinsic (Fas-dependent) pathways regulate the life and death of lymphocytes. Our results identify that Bid plays an important regulatory role in CD8 + T cell death in vivo during persistent infection. The regulation of T cell death during acute or chronic infections is ultimately determined by the balance between the proapoptotic factors and their prosurvival counterparts. The mitochondrial pathway is regulated by proteins of the Bcl-2 family that dominate during acute infections, whereas the death receptor pathway involves membrane receptors of the TNFR1 family, which play an additional role in chronic infections. In this study, we show that part of this synergy to eliminate lymphocytes in chronic immune responses is mediated through Bid to optimize removal of activated CD8 + T cells.
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